International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 4214-4218
Research Article
A Comparative Study on the Effectiveness of Enhanced Recovery After Surgery (ERAS) Versus Conventional Management in Patients Undergoing Gastrointestinal Surgeries
 ,
 ,
Received
May 13, 2026
Accepted
June 5, 2026
Published
June 24, 2026
Abstract

Background: Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care pathway designed to reduce surgical stress and improve postoperative recovery. Its implementation in gastrointestinal surgery has demonstrated improved clinical outcomes. Objective: To compare the effectiveness of ERAS protocols with conventional perioperative management in patients undergoing gastrointestinal surgeries. Methods: A prospective cohort observational study was conducted among 50 patients undergoing elective gastrointestinal surgery between July 2022 and June 2024. Patients were divided into ERAS and conventional management groups. Outcomes assessed included length of hospital stay, time to first bowel movement, postoperative pain scores, complications, and patient satisfaction. Results: The ERAS group demonstrated significantly reduced hospital stay (6.0 ± 1.5 vs 7.2 ± 1.8 days; p = 0.024), earlier bowel recovery (1.5 ± 0.5 vs 2.5 ± 0.8 days; p < 0.001), and lower pain scores (4.0 ± 1.5 vs 5.0 ± 1.8; p = 0.039). Complication rates and patient satisfaction were comparable between groups. No mortality was observed. Conclusion: ERAS protocols significantly enhance postoperative recovery and reduce hospital stay and pain without increasing complications. Adoption of ERAS pathways can improve surgical outcomes and healthcare efficiency.

Keywords
INTRODUCTION

Enhanced Recovery After Surgery (ERAS) represents a paradigm shift in perioperative care aimed at minimizing surgical stress, preserving physiological function, and accelerating postoperative recovery. First introduced by Kehlet in 1997, ERAS integrates evidence-based surgical, anesthetic, and nursing strategies to optimize patient outcomes.

 

Traditional perioperative practices such as prolonged fasting, routine use of nasogastric tubes and drains, delayed feeding, and extended immobilization have been challenged due to limited scientific evidence supporting their effectiveness. ERAS protocols emphasize patient education, reduced preoperative fasting, multimodal analgesia, early mobilization, early enteral nutrition, and goal-directed fluid therapy.

 

Surgical stress contributes significantly to postoperative morbidity, delayed recovery, and prolonged hospitalization. ERAS pathways attenuate this stress response, reducing complications, healthcare costs, and length of stay while improving patient satisfaction and recovery quality.

 

Although ERAS is widely accepted in colorectal surgery, further evaluation in broader gastrointestinal procedures is essential to strengthen its adoption in routine surgical practice.

 

MATERIALS AND METHODS

Study Design

Prospective cohort observational study.

 

Study Setting

Department of General Surgery and Surgical Gastroenterology, GMKMCH, Salem, Tamil Nadu, India.

 

Study Period                                                                                                                                                       

July 2022 – June 2024.

 

Sample Size

50 patients undergoing elective gastrointestinal surgery.

 

Inclusion Criteria

  • Patients >12 years of age
  • Elective open gastrointestinal surgeries

 

Exclusion Criteria

  • Laparoscopic surgeries
  • Emergency surgeries
  • Relaparotomies
  • Immunocompromised patients

 

Study Groups

ERAS Group: Managed using ERAS protocol

Conventional Group: Managed using traditional perioperative care

 

ERAS Protocol Components

  • Preoperative counseling and optimization
  • Reduced fasting and carbohydrate loading
  • Multimodal opioid-sparing analgesia
  • Early removal of drains and tubes
  • Early mobilization
  • Early enteral feeding
  • Goal-directed fluid therapy

 

Data Collection

The following variables were recorded:

  • Demographic characteristics
  • Comorbidities
  • Surgical duration
  • Postoperative recovery parameters
  • Pain scores
  • Complications
  • Patient satisfaction

 

Outcome Measures

Primary Outcomes

  • Length of hospital stay
  • Time to first bowel movement

 

Secondary Outcomes

  • Pain scores
  • Complications
  • Patient satisfaction

 

Statistical Analysis

Data were analyzed using appropriate statistical tests. A p-value < 0.05 was considered statistically significant.

 

RESULTS

Baseline Characteristics

Table 1: Patient Characteristics

Variable

ERAS

Conventional

p-value

Mean Age (years)

28.5 ± 6.5

29.8 ± 7.1

0.235

Male (%)

50

51

0.887

BMI

25.3 ± 3.5

24.8 ± 3.7

0.652

Hypertension (%)

50

55

0.617

No significant differences were observed between groups.                                                                              

 

Postoperative Recovery Outcomes

Table 2: Clinical Outcomes

Outcome

ERAS

Conventional

p-value

Hospital Stay (days)

6.0 ± 1.5

7.2 ± 1.8

0.024

First Bowel

Movement

(days)

1.5 ± 0.5

2.5 ± 0.8

<0.001

Pain Score

4.0 ± 1.5

5.0 ± 1.8

0.039

Complications (%)

10

15

0.657

 

Additional Observations

  • No mortality recorded in either group
  • Pain reduction more pronounced among female patients
  • Patients with hypertension had shorter hospital stay in ERAS group

 

Diagram: ERAS Recovery Pathway

Preoperative Optimization → Reduced Fasting → Multimodal Analgesia → Early Feeding → Early Mobilization → Faster Recovery.

 

Source: Yongheng Zhou et al., 2023 7th  

Diagram: Outcome Comparison

ERAS Protocol

  • Faster bowel recovery
  • Lower pain scores
  • Shorter hospital stay

 

Conventional Care

✖ Sl delayed recovery

✖ Higher pain levels

✖ Longer hospitalization

 

DISCUSSION

Enhanced Recovery After Surgery protocols significantly improved postoperative recovery outcomes in patients undergoing gastrointestinal surgery. The groups were comparable at baseline, ensuring that observed differences were attributable to perioperative care pathways.

 

A significant reduction in hospital stay in the ERAS group reflects accelerated functional recovery and improved perioperative management. Early mobilization, early feeding, and optimized pain control contribute to shorter hospitalization, reduced costs, and decreased risk of hospital-acquired infections.

 

Early return of bowel function observed in ERAS patients indicates improved gastrointestinal motility and reduced postoperative ileus. Avoidance of prolonged fasting and opioid-heavy analgesia promotes physiological recovery.

 

Lower postoperative pain scores demonstrate the effectiveness of multimodal analgesia strategies. Reduced opioid use minimizes adverse effects such as nausea, sedation, and delayed bowel recovery.

 

Although complication rates were slightly lower in the ERAS group, the difference was not statistically significant. Importantly, ERAS did not increase complications, confirming its safety profile.

 

Subgroup findings suggest that ERAS may provide additional benefits for female patients and individuals with hypertension, highlighting the importance of individualized perioperative care.

 

These findings align with global literature demonstrating improved recovery outcomes, reduced hospital stay, and enhanced patient comfort with ERAS implementation.

 

Limitations

  • Small sample size
  • Single-center study
  • Exclusion of laparoscopic and emergency surgeries
  • Limited long-term follow-up
  • Future multicenter randomized trials are recommended to validate these findings.

 

CONCLUSION

Enhanced Recovery After Surgery protocols significantly improve postoperative recovery in gastrointestinal surgery. ERAS reduces hospital stay, accelerates bowel recovery, and improves pain control without increasing complications.

 

Adoption of ERAS pathways can enhance surgical outcomes, improve patient experience, and optimize healthcare resource utilization.

 

Ethical Approval

The study was conducted in accordance with institutional ethical standards. Written informed consent was obtained from all participants.

 

Conflict of Interest

The authors declare no conflict of interest.

 

Funding

No external funding was received.

 

REFERENCES:

  1. Kehlet H. Multistress surgical response and recovery.
  2. Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery.
  3. Nelson G, et al. ERAS Society Guidelines.
  4. Gustafsson UO, et al. Perioperative care guidelines.
  5. Lassen K, et al. ERAS protocol outcomes.
  6. Vather R, et al. Postoperative ileus prevention.
  7. Zhou Y,  et al. The effect of the enhanced recovery after surgery program on radical cystectomy: a meta-analysis and systematic review. Front Surg. 2023 May 19.  
Recommended Articles
Research Article Open Access
Suboptimal utilization of advancements in transplants due to a lack of organ donations globally. Are we doing enough to enhance the donation rate? A study from Jeddah, Saudi Arabia
2026, Volume-7, Issue 3 : 4219-4225
Research Article Open Access
A Comparative Study of Mesh Repair Versus Mayo's Repair in Umbilical and Paraumbilical Hernias
2026, Volume-7, Issue 3 : 4158-4165
Research Article Open Access
Diagnostic Utility of Peripheral Blood Biomarkers in Childhood Leukemia: A Prospective Observational Study
2026, Volume-7, Issue 3 : 4187-4197
Research Article Open Access
Ultrasound-Derived Cervical Volume Outperforms Bishop Score in Predicting Successful Labour Induction at Term: A Prospective Observational Study
2026, Volume-7, Issue 3 : 4176-4186
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
4 Views
6 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved